Page 61 - ESHRE2019

MONDAY, 24 JUNE 2019
SELECTED ORAL COMMUNICATIONS
10:00 - 11:30 Haydn 1
Session 03: Biomarkers and signals in endocrinology
Chairs: J.S. Tapanainen (Finland) G. Freude (Austria)
10:00 O-009
10:15 O-010
10:30 O-011
10:45 O-012
Antimullerian Hormone as a driving force of PCOS, independently from insulin-resistance
G. Robin1, M. Deknuydt1, A.L. Barbotin2, P. Pigny3, S. Catteau-Jonard1, D. Dewailly1 1Lille University Hospital, Reproductive Endocrinology Unit, Lille, France
2Lille University Hospital, Reproductive Biology Unit, Lille, France
3Lille University Hospital, Hormonology laboratory, Lille, France
Anti-Müllerian hormone levels in adolescence in relation to long-term follow up for presence of polycystic ovary syndrome
M. Caanen1, H. Peters1, M. Van Hooff2, P.M. Ven3, A.M.M. Jüttner1, J.S. Laven4, C.B. Lambalk1 1Amsterdam UMC- location VUmc, reproductive medicine, Amsterdam, The Netherlands
2Franciscus Hospital, Department of Obstetrics and Gynaecology, Rotterdam, The Netherlands 3Amsterdam UMC- location VUmc, Clinical Epidemiology and Biostatistics, Amsterdam, The Netherlands 4Erasmus MC University Medical Center, Obstetrics & Gynaecology, Rotterdam, The Netherlands
Optimizing follicle-stimulating hormone concentration during human IVM
J. Cadenas1, L.A. Zuniga1, Z. Ghezelayagh1, Y. Wakimoto2, D. Nikiforov1, S.E. Pors1, C.Y. Andersen1
1University Hospital of Copenhagen- Rigshospitalet, Laboratory of Reproductive Biology- The Juliane Marie Centre for Women- Children and Reproduction, Copenhagen, Denmark
2Hyogo College of Medicine, Department of Obstetrics and Gynecology, Nishinomiya, Japan
NK3R antagonist ameliorates metabolic status and reverses obesity in mice
Y. Shi1, X. Zhu1, Y. Liu1
1Shanghai Medical College- Fudan University- Shanghai, Hospital and Institute of Obstetrics and Gynecology, Shanghai, China
SCIENTIFIC PROGRAMME, MONDAY, 24 JUNE I VIENNA, AUSTRIA – 23 TO 26 JUNE 2019 61
SCIENTIFIC PROGRAMME MONDAY, 24 JUNE